WEST LAFAYETTE, Ind., May 25, 2023 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that Robert Leasure Jr., President and…Read More
Related Posts
Digital PCR dPCR and Realtime PCR qPCR Market worth 124 billion MarketsandMarkets
CHICAGO, April 11, 2023 /PRNewswire/ -- The dPCR and qPCR industry is expected to experience significant growth in the near future. This is due to the increasing demand for precise,…
Univercells Technologies Acquired by Donaldson Company Donaldson NYSEDCI
MENLO PARK, Calif., June 30, 2023 /PRNewswire/ -- Gamma Biosciences, a life sciences platform created by global investment firm KKR to address the advanced therapy bioprocessing market, today announced that…
Ultragenyx Pharmaceutical Inc Ultragenyx Appoints Howard Horn as Chief Financial Officer and Executive Vice President…
NOVATO, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases,…
